Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

NCT01794169 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

130

Enrollment

OTHER

Sponsor class

Stopped Poor recruitment

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
DRUG: DA

Sponsor

Karolinska University Hospital

Collaborators

[object Object]